Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage pharmaceutical company, today announces that the Company is establishing a wholly-owned European subsidiary for the purpose of the development of its drug candidates internationally.
The subsidiary will serve as a key hub for strategic collaboration with European companies and medical communities in addition to providing cost-saving efficiencies and flexibility with respect to developing Brilacidin under European Medicines Agency standards.
“The European subsidiary will serve as an important bridge to international markets, where we are seeing particularly strong partnering interest in Brilacidin across multiple indications, recently reinforced by compelling clinical data from our Phase 2 trials for Inflammatory Bowel Diseases and Oral Mucositis. I feel the public markets have yet to fully appreciate the potential of our clinical assets. My swap of debt for Company stock demonstrates my strong belief in our pipeline and team.”
Okay, so how do you think they'll go about this? One way would be to divi us shares into the new entity. Create a new ticker and whala, we now own IPIX and a piece of the new company. The amount we receive is based on how many shares we currently hold. Leo picked up almost 1 Million shares common, of course he still has over 5 million B shares.
Anyway, this could get exciting. It'll certainly be interesting. It really doesn't do anything for us unless, and this would be key, the subsidiary comes with a few Dr.s with deep pockets that are willing to put up a juicy stake themselves. If it comes fully funded, we win big time.
I'm thinking Leo will move pretty quick on this. Possibly over the next couple weeks.
Of course this is just my wild guess.
I certainly wasn't anticipating this move but was of course hopeful. Broken clock is right twice a day right? No, it's not partnership news but it very well could be close.
The subsidiary will serve as a key hub for strategic collaboration with European companies and medical communities in addition to providing cost-saving efficiencies and flexibility with respect to developing Brilacidin under European Medicines Agency standards.
“The European subsidiary will serve as an important bridge to international markets, where we are seeing particularly strong partnering interest in Brilacidin across multiple indications, recently reinforced by compelling clinical data from our Phase 2 trials for Inflammatory Bowel Diseases and Oral Mucositis. I feel the public markets have yet to fully appreciate the potential of our clinical assets. My swap of debt for Company stock demonstrates my strong belief in our pipeline and team.”
Okay, so how do you think they'll go about this? One way would be to divi us shares into the new entity. Create a new ticker and whala, we now own IPIX and a piece of the new company. The amount we receive is based on how many shares we currently hold. Leo picked up almost 1 Million shares common, of course he still has over 5 million B shares.
Anyway, this could get exciting. It'll certainly be interesting. It really doesn't do anything for us unless, and this would be key, the subsidiary comes with a few Dr.s with deep pockets that are willing to put up a juicy stake themselves. If it comes fully funded, we win big time.
I'm thinking Leo will move pretty quick on this. Possibly over the next couple weeks.
Of course this is just my wild guess.
Quote:oh and a *high* DRS % .. tells me NR wasn't *anticipating* today's news ..
in spite of all CDEL's *blocks* on *ask* ..
I certainly wasn't anticipating this move but was of course hopeful. Broken clock is right twice a day right? No, it's not partnership news but it very well could be close.
Quote:01/30/2019 4:10:12 PM
Posted By: BooDog
Re: Drano #52967
Yeah, no doubt. They're trying like hell to suck away the momentum of any move. They have the power, but, news of a partnership will undoubtedly sink them.
Do it Leo & Dr. B, fry em!
Read More: https://investorshangout.com/post/view?id=533...z5eHIXHUye
2
